Y Intercept Hong Kong Ltd Has $1.11 Million Holdings in Teleflex Incorporated $TFX

Y Intercept Hong Kong Ltd decreased its holdings in Teleflex Incorporated (NYSE:TFX) by 82.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,068 shares of the medical technology company’s stock after selling 41,473 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Teleflex were worth $1,110,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of TFX. MassMutual Private Wealth & Trust FSB grew its position in shares of Teleflex by 57.9% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after buying an additional 77 shares during the last quarter. Quent Capital LLC acquired a new position in shares of Teleflex in the third quarter worth approximately $38,000. True Wealth Design LLC lifted its stake in shares of Teleflex by 10,333.3% in the second quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock worth $37,000 after acquiring an additional 310 shares during the period. Salomon & Ludwin LLC bought a new stake in Teleflex in the third quarter valued at approximately $49,000. Finally, Farther Finance Advisors LLC boosted its stake in shares of Teleflex by 151.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 408 shares of the medical technology company’s stock valued at $50,000 after purchasing an additional 246 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Stock Down 1.0%

TFX stock opened at $104.40 on Friday. The stock has a fifty day moving average of $116.10 and a 200-day moving average of $119.60. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $184.34. The company has a market capitalization of $4.61 billion, a price-to-earnings ratio of -14.20, a PEG ratio of 1.38 and a beta of 0.93. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.38 by $0.29. The business had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The firm’s quarterly revenue was up 19.4% compared to the same quarter last year. During the same period in the previous year, the business posted $3.49 EPS. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, equities research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date was Friday, November 14th. Teleflex’s payout ratio is presently -18.50%.

Analysts Set New Price Targets

TFX has been the topic of a number of recent analyst reports. Needham & Company LLC raised Teleflex from a “hold” rating to a “buy” rating and set a $138.00 price objective on the stock in a research note on Tuesday. Wall Street Zen lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Wells Fargo & Company cut their price objective on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a report on Thursday. Finally, Truist Financial boosted their target price on Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research note on Thursday, December 18th. Two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $139.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.